Research programme: Store-operated calcium channel modulators - MediciNova
Alternative Names: Store-operated calcium channel modulators research programmeLatest Information Update: 21 Apr 2006
At a glance
- Originator MediciNova
- Class
- Mechanism of Action Calcium channel antagonists; T cell activation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Inflammation
Most Recent Events
- 21 Apr 2006 No development reported - Preclinical for Cancer in USA (unspecified route)
- 21 Apr 2006 No development reported - Preclinical for Inflammation in USA (unspecified route)
- 11 Mar 2005 This programme is still in active development